Correspondence

Cannabis-based products for medicinal use

A letter to clinicians from the Chief Medical Officer and NHS England following the rescheduling of legislation to allow the medicinal use of cannabis-based products.

• From: Department of Health and Social Care
• Published: 2 November 2018

Documents

Letter from the CMO and NHS England about cannabis-based products for medicinal use

PDF, 177 KB, 6 pages

Details

The letter sets out expectations of what this regulatory change will mean in practice for clinicians working in the NHS and in private practice in England.

Published 2 November 2018